COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,949 Articles (22,604 medRxiv, 8,345 bioRxiv)

Most recent first Previous |  Page 2598: Articles 25971-25980  | Next

Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment: a retrospective cohort study
Zhou, Y., He, X., Zhang, J., Xue, Y. e., Liang, M., Yang, B., Ma, W., Zhou, Q., Chen, L., Wang, X.
10.1101/2020.06.09.20076646 — Posted: 2020-06-10
Stability of SARS-CoV-2 Phylogenies
Turakhia, Y., Thornlow, B., Gozashti, L., Hinrichs, A., Fernandes, J., Haussler, D., Corbett-Detig, R.
10.1101/2020.06.08.141127 — Posted: 2020-06-09
Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins
Shi, Y., Shi, J., Sun, L., Tan, Y., Wang, G., Guo, F., Hu, G., Fu, Y., Fu, Z. F., Xiao, S., Peng, G.
10.1101/2020.06.09.141580 — Posted: 2020-06-09
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
Ding, S., Zang, R., Case, J. B., Gomez Castro, M. F., Liu, Z., Zeng, Q., Zhao, H., Son, J., Rothlauf, P. W., Hou, G., Bose, S., Wang, X., Vahey, M. D., Kirchhausen, T., Fremont, D. H., Diamond, M. S., Whelan, S. P. J.
10.1101/2020.06.08.141077 — Posted: 2020-06-09 Discussion: Onsite | Offsite
Structural basis of a public antibody response to SARS-CoV-2
Yuan, M., Liu, H., Wu, N. C., Lee, C.-C. D., Zhu, X., Zhao, F., Huang, D., Yu, W., Hua, Y., Tien, H., Rogers, T. F., Landais, E., Sok, D., Jardine, J. G., Burton, D. R., Wilson, I. A.
10.1101/2020.06.08.141267 — Posted: 2020-06-09
Molecular modelling predicts SARS-CoV-2 ORF8 protein and human complement Factor 1 catalytic domain sharing common binding site on complement C3b
Singh, J., Kar, S., Ganguly, S., Hasnain, S. E.
10.1101/2020.06.08.107011 — Posted: 2020-06-09
The hypothalamus as a hub for putative SARS-CoV-2 brain infection
Nampoothiri, S., Sauve, F., Ternier, G., Fernandois, D., Coelho, C., Imbernon, M., Deligia, E., Perbet, R., Florent, V., Baroncini, M., Pasquier, F., Trottein, F., Maurage, C.-A., Mattot, V., Giacobini, P., Rasika, S., Prevot, V.
10.1101/2020.06.08.139329 — Posted: 2020-06-09 Discussion: Onsite
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Schmidt, F., Weisblum, Y., Muecksch, F., Hoffmann, H.-H., Michailidis, E., Lorenzi, J. C. C., Mendoza, P., Rutkowska, M., Bednarski, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Caskey, M., Robbiani, D. F., Nussenzweig, M. C., Rice, C. M., Hatziioannou, T., Bieniasz, P. D.
10.1101/2020.06.08.140871 — Posted: 2020-06-09 Discussion: Onsite | Offsite
Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma
Salazar, E., Kuchipudi, S. V., Christensen, P. A., Eagar, T. N., Yi, X., Zhao, P., Jin, Z., Long, S. W., Olsen, R. J., Chen, J., Castillo, B., Leveque, C., Towers, D. M., Lavinder, J., Gollihar, J. D., Cardona, J., Ippolito, G. C., Nissly, R. H., Bird, I. M., Greenawalt, D., Rossi, R. M., Gontu, A., Srinivasan, S., Poojary, I. B., Cattadori, I. M., Hudson, P. J., Joselyn, N., Prugar, L., Huie, K., Herbert, A., Bernard, D. W., Dye, J., Kapur, V., Musser, J. M.
10.1101/2020.06.08.138990 — Posted: 2020-06-09
Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes
Takahashi, T., Wong, P., Ellingson, M., Lucas, C., Klein, J., Israelow, B., Silva, J., Oh, J., Mao, T., Tokuyama, M., Lu, P., Venkataraman, A., Park, A., Liu, F., Meir, A., Sun, J., Wang, E., Wyllie, A. L., Vogels, C. B. F., Earnest, R., Lapidus, S., Ott, I., Moore, A., Casanovas, A., Dela Cruz, C., Fournier, J., Odio, C., Farhadian, S., Grubaugh, N., Schultz, W., Ko, A., Ring, A., Omer, S., Iwasaki, A., Yale IMPACT research team
10.1101/2020.06.06.20123414 — Posted: 2020-06-09 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).